Long non‐coding RNA as a novel biomarker and therapeutic target in aggressive B‐cell non‐Hodgkin lymphoma: A systematic review

• Published in: Journal of cellular and molecular medicine Vol. 27; no. 14; pp. 1928 - 1946
• Main Authors: Khanmohammadi, Shaghayegh, Fallahtafti, Parisa
• Format: Journal Article
• Language: English
• Published: England John Wiley & Sons, Inc 01.07.2023; John Wiley and Sons Inc
• Subjects: Adult; aggressive non‐Hodgkin lymphoma; Apoptosis; B-cell lymphoma; biomarker; Biomarkers; Burkitt Lymphoma - drug therapy; Burkitt's lymphoma; Cell cycle; Cell migration; Cell proliferation; Chemotherapy; Cyclin-dependent kinases; Diagnosis; diffuse large B‐cell lymphoma; Epigenetics; Growth factors; Humans; Kinases; Leukemia; long non‐coding RNA; Lymphocytes; Lymphocytes B; Lymphoma; Lymphoma, Large B-Cell, Diffuse - diagnosis; Lymphoma, Large B-Cell, Diffuse - drug therapy; Lymphoma, Large B-Cell, Diffuse - genetics; Lymphoma, Mantle-Cell; Mantle cell lymphoma; Non-coding RNA; Non-Hodgkin's lymphoma; non‐Hodgkin lymphomas; Pathogenesis; Prognosis; Proteins; Review; Reviews; RNA, Long Noncoding - genetics; Systematic review; Therapeutic applications; Therapeutic targets; non-Hodgkin lymphomas; aggressive non-Hodgkin lymphoma; mantle cell lymphoma; long non-coding RNA; diffuse large B-cell lymphoma; biomarker; Burkitt's lymphoma

Cancer initiation and progression have been associated with dysregulated long non‐coding RNA (lncRNA) expression. However, the lncRNA expression profile in aggressive B‐cell non‐Hodgkin lymphoma (NHL) has not been comprehensively characterized. This systematic review aims to evaluate the role of lnc...